Filter
385
Filtered Results: 385
Text search:
opioid
sustituition
therapy
Featured
Recommendations
25
New Publications
92
Language
Document type
No document type
298
Studies & Reports
36
Guidelines
29
Manuals
6
Situation Updates
5
Strategic & Response Plan
4
Fact sheets
4
Training Material
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
31
Ukraine
18
Nepal
16
Western and Central Europe
15
Eastern Europe
12
Asia
11
Russia
8
Tajikistan
7
Bangladesh
7
Myanmar / Burma
6
Kenya
5
Albania
5
Cambodia
5
Armenia
4
Global
4
South–East Asia Region
4
Moldova
4
Georgia
4
Indonesia
4
Africa
3
South Africa
3
Ethiopia
3
North Macedonia
2
Estonia
2
Tanzania
2
Middle East and North Africa
2
Vietnam
2
Uganda
2
Zambia
2
Pakistan
2
Serbia
1
Ghana
1
Kazakhstan
1
Nigeria
1
Canada
1
Laos
1
Senegal
1
Kyrgyzstan
1
Afghanistan
1
Malawi
1
Latin America and the Carribbean
1
Sri Lanka
1
Poland
1
Bhutan
1
Liberia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
21
Public Health
5
Women & Child Health
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
HIV
193
Mental Health
45
TB
31
Pharmacy
8
COVID-19
7
Refugee
2
Conflict
2
Rapid Response
1
Social Ethics
1
Caregiver
1
NCDs
1
Polio
1
Global Health Education
1
AMR
1
Accessed: 26.09.2019
UNAIDS 2018, Guidance
Indicators for monitoring the
2016 Political Declaration on Ending AIDS
Clinical Guidance across the continuum of care
Chapter 8_ARV Guidelines
Guidance
Indicators for monitoring the 2016 Political Declaration on Ending AIDS
UNAIDS Joint United Nations Programme on HIV/AIDS
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...
An Evidence-Based Treatment Guide for Clinicians
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
India AIDS Response Report 2014
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
